1.
Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes. J of Skin [Internet]. 2022 Nov. 16 [cited 2025 May 17];6(6):458-62. Available from: https://skin.dermsquared.com/skin/article/view/1778